Toronto Dominion Bank’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $406K | Sell |
23,437
-138,753
| -86% | -$2.4M | ﹤0.01% | 980 |
|
|
2025
Q1 | $3.55M | Sell |
162,190
-834,863
| -84% | -$18.3M | 0.01% | 638 |
|
|
2024
Q4 | $31.8M | Buy |
997,053
+971,431
| +3,791% | +$31M | 0.05% | 199 |
|
|
2024
Q3 | $739K | Buy |
25,622
+1,022
| +4% | +$29.5K | ﹤0.01% | 747 |
|
|
2024
Q2 | $944K | Buy |
24,600
+14,601
| +146% | +$560K | ﹤0.01% | 771 |
|
|
2024
Q1 | $588K | Buy |
+9,999
| New | +$588K | ﹤0.01% | 817 |
|
|
2023
Q3 | – | Sell |
-119
| Closed | -$11K | – | 1601 |
|
|
2023
Q2 | $11K | Buy |
+119
| New | +$11K | ﹤0.01% | 1066 |
|
|
2022
Q1 | – | Sell |
-38,421
| Closed | -$1.82M | – | 1406 |
|
|
2021
Q4 | $1.82M | Buy |
+38,421
| New | +$1.82M | ﹤0.01% | 862 |
|